title: French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010.
abstract: AIM OF FAST-MI 2010:  To gather data on characteristics, management and outcomes of patients hospitalised for acute myocardial infarction (AMI) at the end of 2010 in France.
  
  
  METHODS
  To provide cardiologists and health authorities national and regional data on AMI management every 5 years.
  
  
  METHODS
  Metropolitan France. 213 academic (n=38), community (n=110), army hospitals (n=2), private clinics (n=63), representing 76% of centres treating AMI patients. Inclusion from 1 October 2010.
  
  
  METHODS
  Consecutive patients included during 1 month, with a possible extension of recruitment up to one additional month (132 centres); 4169 patients included over the entire recruitment period, 3079 during the first 31 days; 249 additional patients declining participation (5.6%).
  
  
  METHODS
  Consecutive adults with ST-elevation and non-ST-elevation AMI with symptom onset ≤48 h. Patients with AMI following cardiovascular procedures excluded.
  
  
  METHODS
  Web-based collection of 385 items (demographic, medical, biologic, management data) recorded online from source files by external research technicians; case-record forms with automatic quality checks. Centralised biology in voluntary centres to collect DNA samples and serum. Long-term follow-up organised centrally with interrogation of municipal registry offices, patients' physicians, and direct contact with the patients.
  
  
  METHODS
  Data management in Toulouse University.
  
  
  METHODS
  Université Paris Descartes, Université de Toulouse, Université Pierre et Marie Curie-Paris 06, Paris.
  
  
  METHODS
  In-hospital events; cardiovascular events, hospital admissions and mortality during follow-up. Linkage with Institute for National Statistics.
  
  
  BACKGROUND
  Available for research to any participating clinician upon request to executive committee (fastmi2010@yahoo.fr).
authors.affiliation: Department of Cardiology, Centre hospitalier de Haguenau, Haguenau Cedex, France.
authors.forename: Michel
authors.initials: M
authors.lastname: Hanssen
authors.forename: Yves
authors.initials: Y
authors.lastname: Cottin
authors.forename: Khalife
authors.initials: K
authors.lastname: Khalife
authors.forename: Laure
authors.initials: L
authors.lastname: Hammer
authors.forename: Patrick
authors.initials: P
authors.lastname: Goldstein
authors.forename: Etienne
authors.initials: E
authors.lastname: Puymirat
authors.forename: Geneviève
authors.initials: G
authors.lastname: Mulak
authors.forename: Elodie
authors.initials: E
authors.lastname: Drouet
authors.forename: Benoit
authors.initials: B
authors.lastname: Pace
authors.forename: Eric
authors.initials: E
authors.lastname: Schultz
authors.forename: Vincent
authors.initials: V
authors.lastname: Bataille
authors.forename: Jean
authors.initials: J
authors.lastname: Ferrières
authors.forename: Tabassome
authors.initials: T
authors.lastname: Simon
authors.forename: Nicolas
authors.initials: N
authors.lastname: Danchin
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D017023:Coronary Angiography; D003325:Coronary Care Units / Q000706:statistics & numerical data; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D012042:Registries; D012307:Risk Factors; D013318:Stroke Volume; D015996:Survival Rate / Q000639:trends; D013997:Time Factors; D016896:Treatment Outcome; D016277:Ventricular Function, Left / Q000502:physiology
chemical_list: D000319:Adrenergic beta-Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors